Joakim Falkner > Baker McKenzie > Stockholm, Sweden > Lawyer Profile

Baker McKenzie
VASAGATAN 7, FLOOR 8
PO BOX 180
101 23 STOCKHOLM
Sweden

Work Department

Capital Markets

Position

Joakim Falkner is based in Stockholm and is heading up Baker McKenzie’s Capital Markets Practice Group in Europe, Middle East and Africa. He is ranked as leading lawyer for capital markets by the leading legal directories. Prior to joining Baker McKenzie in 2012, he worked at another global law firm for six years in Stockholm and London. During the last six years (2016-2021), Baker McKenzie’s Capital Markets Group in Stockholm has been ranked #1 in acting for investment banks in capital markets transactions (in terms of deal volume) and #1-3 in acting for issuers in capital markets transactions (in terms of deal volume). Mr. Falkner is qualified to practice in Sweden, England and Wales and has a U.S. LLM from Suffolk University in Boston, United States of America.

Mr. Falkner practices mainly in the fields of equity capital markets and represents late-stage private and publicly traded companies, investment banks, investors, shareholders and sponsors in a wide range of transactions, including pre-IPO transactions, IPOs, public offerings, primary share issuances, preferential rights offering, sell-downs and public mergers and acquisitions.

Languages

English, Swedish

Memberships

  • Swedish Bar Association – Member
  • International Bar Association – Member
  • Law Society of England & Wales – Member

Education

  • Suffolk University Law School (LL.M.) (2009)
  • University of Uppsala (LL.M.) (2002)

Lawyer Rankings

Sweden > Capital markets

(Leading partners)

Joakim Falkner - Baker McKenzie

Baker McKenzie’s Stockholm office sits at the forefront of the equity capital markets space in Sweden, with the team regularly handling IPOs, including on Nasdaq Stockholm and Nasdaq First North Growth Market, as well as rights issuances, ABBs, and public takeovers. The group is regularly instructed by domestic and international investment banks as underwriters’ counsel and is also noted for its life sciences expertise; acting for several banks in relation to Cinclus Pharma’s main market mid-segment IPO is a recent highlight for the team. Practice head Joakim Falkner has considerable experience representing late-stage private and publicly traded companies, investment banks, investors, shareholders, and sponsors on pre-IPO transactions, IPOs, primary share issuances, and preferential rights offerings. Henric Roth is active in the tech and life sciences spaces. Stefan Balazs and senior associate Johanna Flink are also key contacts.